Find an expert

Prof. Amin Abbosh specializes in Medical Microwave Imaging and Microwave and Millimeter-wave Engineering. His work focuses on designing and developing advanced imaging and sensing systems using electromagnetic techniques at radio-wave frequencies.

Prof. Abbosh’s significant contributions include the creation of innovative imaging systems that leverage his expertise in applied electromagnetics and microwave engineering. He has developed comprehensive analytical and computational frameworks, incorporating signal-processing techniques for detection and AI for classification. This approach has led to a new modality for detection and imaging, combining physics-guided and data-driven methods. His work is protected by over 16 patents.

In Communication Technologies, Prof. Abbosh's work focuses on designing flat-panel, low-cost reconfigurable antennas. These antennas form ground satellite terminals that communicate with low-earth-orbit (LEO) satellites, providing reliable broadband access to remote and regional communities. This technology supports e-health services, distance education, and business productivity, and can be used in various on-the-move environments.

Recent News

August, 2019: Post Doctoral Researchers/Resercah Associates/PhD Candidates

A/Prof Abeyratne is accepting (2021) post-doctoral researchers/covering the areas of: pattern recognition, machine learning, respiratory sound analysis, digital signal processing and smart phone programming. Qualified students are invited to apply for PhD scholarships on a competitve basis.

June 2021:

Snore sound based Sleep Apnea diagnostics intellectual property developed by Dr. Udantha Abeyratne and his team are available for commercialisation. The technology is the culmination of 20 years of ground breaking work leading to four patent applications including two granted ones in the USA (the rest are under examination at various stages) and a large portfolio of peer reviewed publications in international scholarly journals. A Matlab implementation of re-trainable technology and performance comparions against American Academy of Sleep Medicine scoring critera of 2007 (AASM 2007) are available. Prior comparisons on Chicago Criteria ("AASM 1999") are also available via peer-reviewed literature. Our software models indicate that the technology can diagnose sleep apnea at a sensitivity and specificity approching that of a standard facility-based polysomnography (sensitivity, specificity around 90%, 90%-- cross validation studies). Note that the model development data sets available to us (n=100 approx) had been scored per AASM 2007 clinical criteria. Thus, the resulting models require a straight-forward re-training (re-calibration) process on AASM 2012 data before they can be used on subjects diagnosed under AASM 2012 criteria (which is the clinical scoring standard in effect since 2012).

-----------------------------------------------------------------------------------------------------------------------

Assoc./Prof. Udantha Abeyratne is the inventor of the cough-sound based respiratory diagnosis technology (ResApp Health Ltd. (ASX: RAP)) and snore sound based sleep apnea diagnosis technology SnoreSounds.

He earned a PhD (Biomedical Engineering) from Drexel University, USA, and MEng and BScEE degrees in Electrical & Electronic Engineering from Tokushima U, Japan and U Peradeniya, (video here) Sri Lanka respectively. He also received formal post-graduate training in Higher Education (Grad Cert , U of Queensland, Australia) and Paediatric Sleep Science (Grad Cert., U of Western Australia, Australia). He is a Senior Member of the Institute of Electrical & Electronic Engineers (IEEE, USA), and a full Member of the American Academy of Sleep Medicine (AASM).

​Dr. Abeyratne started his research career with a paper on coding techniques for low-bandwidth communication channels. His master's thesis was on a machine learning approach to the human brain activity analysis using electroencephalography (EEG, Brain Waves) and evoked potentials. This approach won the best paper award in ISBET Brain Topography Conference (Osaka, Japan, 1990) and also placed Dr. Abeyratne as a finalist at the Young Investigators' Competition in IFMBE World Congress on Medical Physics and Biomedical Engineering, 1991 (Kyoto, Japan). He completed his PhD (1996) with Prof. Athina Petropulu as the advisor, working on Higher-Order-Spectra and medical ultrasound imaging. The thesis developed slice-based low-complexity algorithms for blind signal identification, tumor detection in ultarsound images, and image deconvolution.

Teaching Activities:

Assoc/Prof. Abeyratne has designed and taught university level courses on digital signal processing, electronic circuits, medical and general instrumentation, medical signal processing, medical imaging, control systems, project management and electromagnetic waves. He has supervised both undergraduate and postgraduate dissertation thesis projects in these areas. Within the last decade five students supervised by him won competitive awards at the UQ Innovation Expo.

Current Research Profile:

Assoc./Prof. Abeyratne's research interests encompass digital signal processing, machine learning, medical instrumentation, medical imaging, electrophysiology, bio-signal analysis and electronics. Over the last two decades A/Prof. Abeyratne has conceptualized, initiated and led the development of a number of innovative technologies funded by prestigious granting agencies such as the Bill & Melinda Gates Foundation, Australian Research Council and the A*-Star Singapore. His research programmes are characteristic of unorthodox approaches resulting in pioneering outcomes that produced spin-off companies, patents and scholarly publications. His research has recieved multiple peer accolades at the international level.

1. Electronic Instrument Design: hand-held ultrasound devices for medical, agricultural and industrial use; stethoscopes for the 21st century (The "Magithescope(c)", winner of two UQ Expo awards in 2013, 2014); biomimetic sensing devices (e.g. electronic nose, e-tongue), low-cost, portable electronic devices ("Tricoders") for diagnosing diseases such as apnea, asthma, pneumonia; wearable electrophysiological devices; real-time fatigue measurement and warning systems; hand-held instruments for the condition monitoring of machinery such as power transformers. Development of diagnostic and treatment devices for sleep apnea. Dr. Abeyratne is especially interested in developing accurate, multi-purpose and low-cost in-situ decision devices for applications in resource-poor regions of the world.

2. Diagnostic and Treatment Technology for Sleep Disorders: speech-like analysis of snore and breathing sounds; sleep diagnostic instrument design; sleep polysomnography, brain wave (EEG) analysis in sleep, quantification of fatigue and sleepiness; sleep apnea; design of apnea treatment devices (CPAP, dental devices); interaction of apnea and chronic diseases. mHealth approaches in sleep diagnostics. A/Prof. Abeyratne pioneered speech-like processing of respiratory sounds, leading to patents, papers and a spin-off company. He conceptualized and led the development of EEG based technology to quantifiy sleepiness in real-time in actual work environments. Outcomes of this program have recieved wide coverage in international media outlets due to its groundbreaking nature and the potential impact.

3. Respiratory Diagnostic Technology: diagnostic instrumentation and algorithm design for respiratory illnesses such as pneumonia, bronchiolitis, asthma, bronchiectasis and COPD; cough sound analysis in respiratory medicine; imaging technology for respiratory diagnosis; Portable diagnostic technologies and mHealth approaches for remote resource-poor areas of the world. About 1 million children below the age of 5 yrs die every year of pneumonia alone, mainly in remote resource-poor areas of the world. Poor access to diagnostics and medical treatment are the major reasons for pneumonia fatalities. A/Prof. Abeyratne proposed a ground-breaking new technology to diagnose pneumonia centred about cough sound analysis. For this research Dr. Abeyratne received funding from UQ, UniQuest and the Bill & Melinda Gates Foundation, which lauded the project (Page 4) as an exmaple for an innovative idea with high impact. Outcomes led to scholarly publications and contributed to patents as well as a spinoff company by UQ.

4. Signal Processing and Machine Intelligence: the analysis of bio-signals such as electroencephalography (EEG), electromyography (EMG); speech and industrial sound analysis, bowel sound analysis and the characterisation of inflammatory bowel disease; cardiovascular signal processing, source localization and blind source separation, higher order spectra, wavelets, pattern recognition, classifier design. Developing technology for monitoring the condition of Left Ventricular Assist Devices (LVAD).

5. mHealth: research on smart phone and other consumer devices as a platform for healthcare delivery. A/Prof Abeyratne is actively engaged in developing mHealth diagnostic solutions, including translating and customising sleep and respiratory technologies. He is also in the process of expanding the work to include meaningful deployment of the technology in both the developed and developing worlds, in collaboration with international NGOs, experts in community medicine, and the UQ spin-off companies resulting from the research program. New national and international collaborations are currently being negotiated to fund and facilitate this work.

The Research Team, Past & Present:

Associate professor Udantha Abeyratne, Dr. Keegan Kosasih (Past PhD graduate); Dr Duleep Herath (past PhD gradute, )Dr. Shahin Akhter (Past PhD graduate), Dr. Vinayak Swarnkar (Past PhD graduate ); Dr. Yusuf Amrulloh (Past PhD graduate); Dr. Shaminda de Silva (Past PhD graduate); Dr. Samantha Karunajeewa (Past PhD graduate); Dr. Suren Rathnayake (Past PhD graduate), Dr. Xiao Di (Past PhD graduate), Dr. T. Emoto (Past PhD work in UQ while at UT), ; Mrunal Markendeya (Current PhD Student); Karen McCloy (current PhD student), Ajith Wakwella (Past MPhil graduate); Lee Teck Hock (Past MPhil Graduate), Tang Xiaoyan (Past MPhil Graduate), Dr. Zhang Guanglan (Past MPhil Graduate), Dr. Syed Adnan (Past MPhil Graduate) and many past and present dissertation thesis students.

Research Collaborators:

Dr. Craig Hukins & Brett Duce (Princess Alexandra Hospital), Prof. Y. Kinouchi & Dr. T. Emoto (U of Tokushima, Japan), Dr. Sarah Biggs (Monash), Dr.Simon Smith (QUT), Dr. Chandima Ekanayake (Griffith U), Dr. Paul Porter (PMH Hospital), Prof. Anne Chang (Menzies School of Health Reserach, CDU), Dr. Scott Mckenzie (Princess Charles Hospital), Dr. Nirmal Weeresekera (JKMRC, UQ), Dr. Rina Triasih (Gadjah Mada U, Indonesia), Dr. K. Puvanendran (1998-2002: Singapore General Hospital, Singapore), Prof.Stanislaw Gubanski (Chalmers U, Sweden).

Dr Mark C Allenby is a Senior Lecturer in Biomedical Engineering (2021-ongoing) and an ARC DECRA Fellow (2022-2025) within UQ's School of Chemical Engineering. Mark is also an Adjunct Senior Lecturer at QUT and previously an Advance Queensland Fellow (2019-2022). Mark has principally supervised 5 PhDs and 2 MPhil/RAs, co-supervised 7 PhDs, and has been awarded over $2.8M of funding as chief investigator across 20 competitive funding rounds in 4 years. Mark received a PhD and MSc in chemical engineering from Imperial College London, UK and bachelors degrees in mathematics and chemistry from Pepperdine University, USA. Mark's leadership is exhibited by the:

• 2024 ASBTE Emerging Leadership Award
• 2024 Friends of CCRM Australia Industry Advisory Network
• 2024, 2023, and 2022 Executive Board Member of ASBTE
• 2023 TERMIS-AP Young Investigator Award
• 2023 RegMedNet Rising Star Finalist
• 2020 QUT ECR Award

Research Interests: Mark leads the BioMimetic Systems Engineering (BMSE) Lab. In the BMSE Lab, we combine Tissue Engineering, Biomedical Image Analysis, and Computational Biology to study and solve biological and medical problems using advanced cell culture and computer models. Initially, we will focus on Systems of Blood, Blood Vessels, and Vascularised Tissue as these are essential building blocks for human and mammalian function. Our work aligns with bioprocess engineering fundamentals, cell therapy or medical device manufacturing, and clinical collaborators in haematology, vascular surgery, neurosurgery, and radiology. Our systems engineering approaches allow us to examine, computationally model, experimentally engineer, optimise, control, scale, and automate dynamic systems of several entities such as multi-cellular tissues or cell-material and cell-fluid systems.

Academic Interests: Mark is the Convener of UQ's Biomedical Engineering (BME) major, ranked #2 in Australia. BME at UQ spans schools of Chemical Engineering (ChE; #1 in Australia), Electrical Engineering, and Mechanical Engineering, and engages with UQ's Faculty of Medicine and associated healthcare services. Mark is part of ChE teaching and scholarship committees, and Mark acts as the academic advisor for ChE-BME undergraduates. Mark is the creator and coordinator of Quantitative Methods in Biomedical Engineering, and is a lecturer of Process Modeling & Dynamics. Mark has previously taught courses in biomaterials, process modelling, and reaction engineering in ChE and BME departments at three universities in the UK and Australia.

Our BMSE Lab is currently looking for excellent computational researchers. These include candidates and collaborators with experience in microscopy and medical image processing, cell population dynamics simulation, and/or biomechanics simulations (Python, MATLAB, R, ANSYS) to analyse high-content experimental data. Postdoc candidates are welcome to contact us to explore fellowship applications. Interested PhD and MPhil candidates should consider applying with us to the UQ Annual HDR Scholarship Round. We are always recruiting masters and undergraduate thesis project students for thesis projects advertised on our lab website.

I am the Group Leader of Bio-inspired Materials Research at the Australian Institute for Bioengineering and Nanotechnology, The University of Queensland. Our research focuses on transforming agricultural waste into innovative solutions for tackling plastic and food waste issues. Our mission extends beyond research and into commercialisation. We are dedicated to fostering partnerships across industry, academia, and government, utilising waste as a valuable resource for advancements in the environment, food and health sectors. Our approach is clear: turning challenges into opportunities for a sustainable future.

I am a strong advocate for cultural diversity and equity, and support staff and students to grow as more effective leaders and create social good.

In recognition of my contribution to the field of nanomaterials engineering and research excellence, I have received several awards including; one of the winners of AgriFutures Australia and growAG.Catalyst Program(2024), one of the Queelsnand Tall Poppy Award winners(2024), The Eight Australian Women Who Are Shaking up the World Of Science (Marie Claire, 2020), one of Australia’s Top 5 Scientists (ABC/UNSW, 2018), Queensland Women in STEM Prize- judges choice award (2017), Women in Technology Life Sciences and/or Infotech Rising Star Award (2016), AIBN Research Excellence Award (2016), a Class of 2014 Future Leader award and Best poster prize at the Australian Nanotechnology Network ECR Entrepreneurship workshop(2015).

Nigel is public health and health services researcher with interests and expertise in quantitative research methods, epidemiology, evidence-based health care, clinical trials, and digital health. He is a member of the Improving health outcomes after musculoskeletal injury group at the RECOVER Injury Research Centre, and is a chief investigator of the NHMRC Centre for Research Excellence in Better Outcomes for Compensable Injury. His work focusses on the epidemiology and burden of minor to moderate injuries, longitudinal data analyses of intervention trial data, population studies of health-related quality of life and chronic pain, and the potential of digital heath for assessment and intervention following injury.

Nigel has particular interests in new innovations in healthcare, and has previously worked in minimally-invasive surgical trials in gynaecology, and clinical trials assessing the feasibility, efficacy and effectiveness of clinical telemedicine in paediatric healthcare. His doctorate work (Awarded 2011, UQ School of Medicine) involved the design, development, and clinical/cost/acceptability evaluation of real-time telemedicine for acute consultation between a tertiary neonatal intensive care unit and four peripheral referring hospitals in Queensland. He maintains an active research interest in telemedicine, and more broadly in digital health. Between 2004 and 2015, Nigel was involved in the telepaediatric service at the Royal Children's, and the Lady Cilento Children's hospitals in Brisbane where he also co-ordinated an Indigenous Ear Health Screening Program. He is an associate editor of the Journal of Telemedicine and Telecare and an academic editor for PLOS ONE.

Nigel regularly participates in national and international grant review panels, and is an active HDR and occupational-trainee supervisor. He is a Fellow of the Royal Society of Medicine and the Royal Society for Public Health (FRSPH), a member of the Australian Epidemiological Association (AEA), International Epidemiological Association (IEA), the International Association for the Study of Pain (IASP), the Association for Interdisciplinary Meta-Research and Open Science (AIMOS), and is a qualified Justice of the Peace, JP (qual).

Experienced materials engineering researcher with proven experience in developing chemically tuned structures for commercial opportunities. My unique skill set spans interfacing technical analysis (morphology, composition, performance, and durability) of sustainable composite materials with economic feasibility and quality system requirements from research and industry associates. I am a team player, and the guiding principles by which I function in all facets of my life include ‘shared values’, ‘shared vision’, ‘complementary expertise’ and ‘diligence’.

Markus graduated from the Vienna University of Technology in Technical Physics in 1995 and was awarded his Doctorate in 1999 after which he worked as postdoctoral research associate and then Assistant Professor at the Department of Radiodiagnostics, Medical University Vienna (AT). From 2004 he worked as Senior Researcher at the Donders Institute for Brain, Cognition and Behaviour (Radboud University Nijmegen, NL) and at the Erwin L. Hahn Institute for Magnetic Resonance Imaging (University Essen-Duisburg, DE). In 2014 he relocated to the University of Queensland to head the Ultra-high Field Human MR Research program at the Centre for Advanced Imaging and was awarded an ARC Future Fellowship. In 2019 he joined the School of Information Technology and Electrical Engineering as Full Professor MR Physics and Medical Imaging and has been appointed as Director for the National Imaging Facility – Queensland Node.

Shakes an imaging expert that leads a strong deep learning, artificial intelligence (AI) focused research team interested in medical image analysis and signal/image processing applied to many areas of science and medicine. He received his Ph.D in Theoretical Physics from Monash University, Melbourne and has been involved in applying machine learning in medical imaging for over a decade.

Shakes’ past work has involved developing shape model-based algorithms for knee, hip and shoulder joint segmentation that is being developed and deployed as a product on the Siemens syngo.via platform. More recent work involves deep learning based algorithms for semantic segmentation and manifold learning of imaging data. Broadly, he is interested in understanding and developing the mathematical basis of imaging, image analysis algorithms and physical systems. He has developed algorithms that utilise exotic mathematical structures such as fractals, turbulence, group theoretic concepts and number theory in the image processing approaches that he has developed.

He is currently a Senior Lecturer and leads a team of 20+ researchers working image analysis and AI research across healthcare and medicine. He currently teaches the computer science courses Theory of Computation and Pattern Recognition and Analysis.

Dr Kai-Hsiang Chuang received his Ph.D. degree in electrical and biomedical engineering from the National Taiwan University, Taiwan, in 2001. During his graduate study, he developed methods for improving the detection of brain activity using functional magnetic resonance imaging (fMRI). He undertook postdoctoral research at the National Institutes of Health, USA, from 2003 to 2007, where he focused on understanding brain connectivity using novel functional and molecular imaging. He developed manganese-enhanced MRI for high-resolution imaging functional neural pathways in the rodent brain and cerebral blood flow imaging for mapping the resting-state network of the human brain. He joined the Agency for Science Technology and Research (A*STAR), Singapore, in 2008 as the head of MRI Group in the Singapore Bioimaging Consortium (a national research institute). He established the first preclinical imaging facility in Singapore and facilitated research collaboration across academia, clinic and industry. His lab pioneered functional connectivity imaging of the rodent brain to understand the neural basis and function of resting-state brain network, and the development and application of MRI biomarkers for treatment development. In late 2015, he moved to the University of Queensland, Australia, as an Associate Professor with the Queensland Brain Institute and the Centre for Advanced Imaging. His current research focuses on understanding the structure and function of brain network that underlies cognition and behavior, such as learning, memory and dementia. He is developing multimodal techniques, including fMRI, calcium recording, electrophysiology and optogenetic/chemogenetic neuromodulation, to test hypothesis in transgenic mouse models and then translating to humans to improve the diagnosis and intervention of disorders. The imaging and analysis techniques he developed have been widely used in the research community and some in clinical trials. He is serving on the editorial boards of Frontiers in Neuroscience: Brain Imaging Methods, Imaging Neuroscience and Scientific Reports.

Professor Simon Cool is Professor of Bioengineering and Director of the UQ Advanced Cell Therapy Manufacturing Initiative in the School of Chemical Engineering at the University of Queensland.

Professor Cool began his scientific career at the University of Queensland more than 20 years ago. He received his BSc (hons) and PhD degrees from the University of Queensland, where he subsequently held a faculty position in the School of Biomedical Sciences. His areas of studies have included age-related changes in the structure of bone and teeth and the extracellular matrix compartment of skeletal tissue that guide stem cell behaviour and wound repair. Professor Cool was invited to join the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore in 2003 as a Principal Investigator. He then joined A*STAR’s Institute of Medical Biology (IMB) in 2008, shortly after its inception, to further his research in regenerative medicine, serving as Senior Principal Investigator of the Glycotherapeutics Group. In October 2020, Professor Cool re-joined the Institute of Molecular and Cell Biology (IMCB) as a Research Director, Glycotherapeutics, where he focused on developing novel glycosaminoglycan biomolecules that enhance wound repair and control adult human mesenchymal stem cell activity.

Professor Cool has 117 patent applications across 26 families with 51 granted in the fields of glycosaminoglycan biochemistry, regenerative medicine and stem cell science. He has more than 150 publications and continues to foster strong strategic collaborations both nationally and internationally with academic and industry groups. He has a strong biomanufacturing and translational focus with experience in taking glycosaminoglycan-based devices through discovery RnD on to pre-clinical and clinical testing. Professor Cool also has an entrepreneurial and licensing background having successfully spun-off some of his technology to a US-based regenerative medicine start-up company, SMC Biotechnology Ltd. Professor Cool holds a Visiting Professor appointment at the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore and an Adjunct Professor (Research) appointment in the Orthopaedic Department at the National University of Singapore (NUS). Prior to his move back to UQ, he previously held the position of Treasurer, Tissue Engineering and Regenerative Medicine International Society, Asia Pacific Chapter (TERMIS-AP) and Treasurer, Stem Cell Society Singapore (SCSS). He also held senior leadership positions in several Singapore-based R&D programmes, notably as Director, Allogeneic Stem Cell Manufacturing (ASTEM) and Theme Leader in Advanced Manufacturing for Biological Materials (AMBM). Prof Cool currently serves on the Editorial Board of the journals Biomaterials, Tissue Engineering and Regenerative Medicine, and is Asia-Pacific Regional Editor for Stem Cells and Development.

Professor Justin Cooper-White is a global leader in using engineering to solve problems in biology. In addition to holding the position of Head of School and Professor of Bioengineering in the School of Chemical Engineering, he is Affiliate Professor in the AIBN, Director of the Australian National Fabrication Facility-Queensland Node, Research Director of the Herston Biofabrication Institute (a partnership between UQ and MNHHS) and co-Director of the Australian Organoid Facility at UQ. Professor Cooper-White is a past President of both the Australasian Society for Biomaterials and Tissue Engineering and the Australian Society of Rheology and held the position of CSIRO Office of the Chief Executive (OCE) Science Leader. He has previously held a Visiting Professor Fellowships at ETH Zurich (2007) and Politecnico di Milano (2012-2013). Professor Cooper-White is the Australian representative and Past President of the Asian Biomaterials Federation; an elected Fellow of and Australian representative on the International Union of Societies for Biomaterials Science and Engineering (IUSBE), and an elected Fellow and past vice President of the Queensland Academy of Arts and Sciences.

Professor Cooper-White has many past and currently active international collaborations with world leading research groups at MIT (US); Stanford (USA); ETH (Switzerland); EPFL (Switzerland); SNU (Korea); University Of Grenoble (France); Politecnico di Milano (Italy); UCL (UK); and the Max Planck Institute (Germany). He has performed contract research and consultancy work for many multinational companies, including Unilever in the UK; Nestle International, Switzerland; Rhodia, US; Inion, Finland, Syngenta, UK; and NuFarm, AU since 2001.

He is the Editor-in-Chief of APL Bioengineering (American Institute of Physics Publishing); serves or has served on the editorial boards of Rheological Acta, Soft Materials, Biomicrofluidics and the Open Biomedical Engineering Journal; and is a reviewer of major international journals, including Nature Materials, Nature Methods, Advanced Materials, Lab on a Chip, Stem Cells, Stem Cells and Development, Biomacromolecules, Tissue Engineering, Langmuir, Biomaterials and Journal of Non-Newtonian Fluid Mechanics.

my research interests are in the design of diagnostic medical devices and new applications for those devices

Prof Crozier is the director of Biomedical Engineering at UQ. He holds a higher doctorate in engineering for his work in improving the technology of imaging equipment. Stuart was elelcted as a fellow of the institute of physics (UK) in 2004 and hold many national and international grants relating to medical imaging and medical devices.

Eminent Staff Specialist in Neonatology (Consultant Neonatologist) - Grantley Stable Neonatal Unit, Royal Brisbane & Women’s Hospital

Associate Professor of Neonatology - Department of Paediatrics and Child Health, University of Queensland

Mark Davies is a medical graduate of the University of Queensland (MB,BS 1985). He trained in Paediatrics at the Royal Children's Hospital (Brisbane), with time at the Worcester Royal Infirmary, Doncaster Royal Infirmary and the Royal Hospital for Sick Children (Glasgow) in the UK.

Mark sub-specialised in Neonatology training at the Royal Women's Hospital (Brisbane), the Rosie Maternity Hospital (Cambridge) and the Glasgow Royal Maternity Hospital. His advanced training was conducted under the supervision of the Neonatal-Perinatal Specialist Advisory Committee of the Royal Australasian College of Physicians (RACP) and he became a Fellow of the RACP in 1997. He completed a two year fellowship training programme in Neonatology and Neonatal Ultrasound at the Royal Women's Hospital (Melbourne) in January 1999.

In July 2000, Mark was appointed to the joint position of Staff Neonatologist at the Royal Women's Hospital, Brisbane and Senior Lecturer in Neonatology at the University of Queensland. He is now an Eminent Staff Specialist in Neonatology and an Associate Professor of Neonatology.

Mark Davies’ research focused on neonatal ventilation. He did his PhD studies on partial liquid ventilation. He supervises projects in neonatology and neonatal intensive care.

Mark prepares and maintains a number of Cochrane systematic reviews in neonatology and intensive care. From 2002 to 2006 he served on the Cochrane Collaboration Steering Group, and was Co-Chair of the steering group from 2005 to 2006. He was a Director of The Cochrane Collaboration Trading Company from 2013 to 2017.

Dr Fernando's current research interests include developing needle-free, pain-free, skin patch vaccines. Influenza and human papilloma virus vaccines are used as model vaccines in these studies.

Dr Germain Fernando completed PhD at the University of Arizona, USA, and did post-doctoral research at the Baylor College of Medicine, Houston, Texas, USA, before joining the University of Queensland in 1989. He has been working in the field of vaccinology for the last 28 years. He has a H-Index of 36.

He is a Senior Consultant at Vaxxas Pty. Ltd, Brisbane, Australia

Publications and Citation Metrics are available at the following website:

http://www.researcherid.com/rid/C-3733-2009